Les histones désacétylases : Nouvelles cibles pour les thérapies anti-cancéreuses = Histone deacetylases : a new class of efficient anti-tumor drugsMOTTET, Denis; CASTRONOVO, Vincent.MS. Médecine sciences. 2008, Vol 24, Num 8-9, pp 742-746, issn 0767-0974, 5 p.Article

Reduced glutathione system: role in cancer development, prevention and treatment (review)LOCIGNO, Roberto; CASTRONOVO, Vincent.International journal of oncology. 2001, Vol 19, Num 2, pp 221-236, issn 1019-6439Article

Galectin-3 and cancer (Review)CALIFICE, Stéphane; CASTRONOVO, Vincent; VAN DEN BRULE, Frédéric et al.International journal of oncology. 2004, Vol 25, Num 4, pp 983-992, issn 1019-6439, 10 p.Article

Innovative Proteomics for the Discovery of Systemically Accessible Cancer Biomarkers Suitable for Imaging and Targeted TherapiesTURTOI, Andrei; DE PAUW, Edwin; CASTRONOVO, Vincent et al.The American journal of pathology. 2011, Vol 178, Num 1, pp 12-18, issn 0002-9440, 7 p.Article

Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3CALIFICE, Stéphane; CASTRONOVO, Vincent; BRACKE, Marc et al.Oncogene (Basingstoke). 2004, Vol 23, Num 45, pp 7527-7536, issn 0950-9232, 10 p.Article

S-acetyl-glutathione selectively induces apoptosis in human lymphoma cells through a GSH-independent mechanismLOCIGNO, Roberto; PINCEMAIL, Joel; HENNO, Audrey et al.International journal of oncology. 2002, Vol 20, Num 1, pp 69-75, issn 1019-6439Article

Increased expression of galectin-I in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patientsVAN DEN BRULE, Frédéric A; WALTREGNY, David; CASTRONOVO, Vincent et al.Journal of pathology. 2001, Vol 193, Num 1, pp 80-87, issn 0022-3417Article

Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiationWALTREGNY, David; ALAMI, Younes; CLAUSSE, Nathalie et al.The Prostate. 2002, Vol 50, Num 3, pp 162-169, issn 0270-4137Article

Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressivenessCHAPLET, Michaël; WALTREGNY, David; DETRY, Cédric et al.International journal of cancer. 2006, Vol 118, Num 4, pp 850-856, issn 0020-7136, 7 p.Article

Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterusDE LEVAL, Laurence; WALTREGNY, David; BONIVER, Jacques et al.The American journal of surgical pathology. 2006, Vol 30, Num 3, pp 319-327, issn 0147-5185, 9 p.Article

Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesionCLAUSSE, Nathalie; VAN DEN BRULE, Frédéric; WALTREGNY, David et al.Angiogenesis (London). 1999, Vol 3, Num 4, pp 317-325, issn 0969-6970Article

Detection of the 67-kD laminin receptor in prostate cancer biopsies as a predictor of recurrence after radical prostatectomyWALTREGNY, David; DE LEVAL, Laurence; COPPENS, Luc et al.European urology. 2001, Vol 40, Num 5, pp 495-503, issn 0302-2838Article

Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysisCONROTTO, Paolo; ROESLI, Christoph; RYBAK, Jascha et al.International journal of cancer. 2008, Vol 123, Num 12, pp 2856-2864, issn 0020-7136, 9 p.Article

Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthaseSTRESING, Verena; FOURNIER, Pierrick G; BELLAHCENE, Akeila et al.Bone (New York, NY). 2011, Vol 48, Num 2, pp 259-266, issn 8756-3282, 8 p.Article

Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic methodCASTRONOVO, Vincent; KISCHEL, Philippe; GUILLONNEAU, Francois et al.Proteomics (Weinheim. Print). 2007, Vol 7, Num 8, pp 1188-1196, issn 1615-9853, 9 p.Article

The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cellsTURTOI, Andrei; MOTTET, Denis; CASTRONOVO, Vincent et al.Angiogenesis (London). 2012, Vol 15, Num 4, pp 543-554, issn 0969-6970, 12 p.Article

Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastomaSAIDI, Ahlame; JAVERZAT, Sophie; BELLAHCENE, Akeila et al.International journal of cancer. 2008, Vol 122, Num 10, pp 2187-2198, issn 0020-7136, 12 p.Article

Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectinVAN DEN BRULE, Frédéric; CALIFICE, Stéphane; GARNIER, Frédérique et al.Laboratory investigation. 2003, Vol 83, Num 3, pp 377-386, issn 0023-6837, 10 p.Article

Dentin matrix protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylationPIROTTE, Sophie; LAMOUR, Virginie; LAMBERT, Vincent et al.Blood. 2011, Vol 117, Num 8, pp 2515-2526, issn 0006-4971, 12 p.Article

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factorSTABILE, Helena; MITOLA, Stefania; CASTRONOVO, Vincent et al.Blood. 2007, Vol 109, Num 5, pp 1834-1840, issn 0006-4971, 7 p.Article

A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burdenLE GALL, Céline; BELLAHCENE, Akeila; BONNELYE, Edith et al.Cancer research (Baltimore). 2007, Vol 67, Num 20, pp 9894-9902, issn 0008-5472, 9 p.Article

Histone Deacetylase 7 Silencing Alters Endothelial Cell Migration, a Key Step in AngiogenesisMOTTET, Denis; BELLAHCENE, Akeila; PIROTTE, Sophie et al.Circulation research. 2007, Vol 101, Num 12, pp 1237-1246, issn 0009-7330, 10 p.Article

Dual Function of ERRα in Breast Cancer and Bone Metastasis Formation: Implication of VEGF and OsteoprotegerinFRADET, Anaïs; SOREL, Helène; CLEZARDIN, Philippe et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 17, pp 5728-5738, issn 0008-5472, 11 p.Article

Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signalingDEROANNE, Christophe F; BONJEAN, Karine; CASTRONOVO, Vincent et al.Oncogene (Basingstoke). 2002, Vol 21, Num 3, pp 427-436, issn 0950-9232Article

Myoferlin Is a Key Regulator of EGFR Activity in Breast CancerTURTOI, Andrei; BLOMME, Arnaud; DELVENNE, Philippe et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 17, pp 5438-5448, issn 0008-5472, 11 p.Article